# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-268113
Filing Date
2025-11-06
Accepted
2025-11-06 07:48:37
Documents
94
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lnth-20250930.htm iXBRL | 10-Q | 3601579
2 | EX-10.1 | lnth-ex10_1.htm | EX-10.1 | 2145235
3 | EX-31.1 | lnth-ex31_1.htm | EX-31.1 | 19180
4 | EX-31.2 | lnth-ex31_2.htm | EX-31.2 | 19463
5 | EX-32.1 | lnth-ex32_1.htm | EX-32.1 | 20010
6 | GRAPHIC | img148029422_0.jpg | GRAPHIC | 3517
| Complete submission text file | 0001193125-25-268113.txt |  | 16288998

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | lnth-20250930.xsd | EX-101.SCH | 1518982
97 | EXTRACTED XBRL INSTANCE DOCUMENT | lnth-20250930_htm.xml | XML | 2880551

Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 251456224
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)